Kathryn A. Grenier
Corporate Officer/Principal bij CANCER PREVENTION PHARMACEUTICALS INC
Profiel
Kathryn A.
Grenier is currently working as Technical Advisors at Cancer Prevention Pharmaceuticals, Inc. She previously worked as Associate Director-Clinical Trials at the University of Arizona and Arizona Cancer Center.
She also held Vice President-Clinical Affairs positions at Somnus Medical Technologies, Inc., Gyrus Group Ltd., and AmpliMed Corp.
Additionally, she worked as a Principal at Becton Dickinson Immunocytometry Systems.
Ms. Grenier received her undergraduate degree from the University of Utah and her graduate degree from the University of San Francisco.
Actieve functies van Kathryn A. Grenier
| Bedrijven | Functie | Begin |
|---|---|---|
| CANCER PREVENTION PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Eerdere bekende functies van Kathryn A. Grenier
| Bedrijven | Functie | Einde |
|---|---|---|
Arizona Cancer Center
 Arizona Cancer Center Miscellaneous Commercial ServicesCommercial Services Part of University of Arizona, Arizona Cancer Center provides clinical and medical research services. The company is based in Tucson, AZ. | Corporate Officer/Principal | - |
Becton Dickinson Immunocytometry Systems
 Becton Dickinson Immunocytometry Systems Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Becton Dickinson Immunocytometry Systems manufactures medical instruments. The company is based in San Jose, CA. | Corporate Officer/Principal | - |
Gyrus Group Ltd.
 Gyrus Group Ltd. Medical SpecialtiesHealth Technology Gyrus Group Ltd. designs, develops, manufactures and markets electro-surgical systems. It operates in four segments: surgical, urology, gynaecology, ent, and partnered technologies. The firm supplies medical devices which reduce trauma and complications in surgery and develops tissue management systems, instruments and services. Gyrus Group was founded in 1989 and is headquartered in London, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | - |
Somnus Medical Technologies, Inc.
 Somnus Medical Technologies, Inc. Medical SpecialtiesHealth Technology Somnus Medical Technologies, Inc. designs, develops, manufactures, and markets medical devices. Its products utilizes proprietary temperature-controlled radiofrequency technology for the treatment of upper airway disorders in a procedure called somnoplasty. The company was founded on April 9, 1996 and is headquartered in Sunnyvale, CA. | Hoofd Techniek/Wetenschap/O&O | - |
| University of Arizona | Corporate Officer/Principal | - |
Opleiding van Kathryn A. Grenier
| University of Utah | Undergraduate Degree |
| University of San Francisco | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Somnus Medical Technologies, Inc.
Somnus Medical Technologies, Inc. Medical SpecialtiesHealth Technology Somnus Medical Technologies, Inc. designs, develops, manufactures, and markets medical devices. Its products utilizes proprietary temperature-controlled radiofrequency technology for the treatment of upper airway disorders in a procedure called somnoplasty. The company was founded on April 9, 1996 and is headquartered in Sunnyvale, CA. | Health Technology |
AmpliMed Corp.
 AmpliMed Corp. Pharmaceuticals: MajorHealth Technology AmpliMed Corp. develops and manufactures drugs to treat cancer. Its products include amplimexon, amplizone and benzimidazole series. The firm is focused on the development of small-molecule oncology drugs with novel mechanisms of action. The company was founded by Evan M. Hersh, David S. Alberts, Robert Thomas Dorr and William A. Remers in 1989 and is headquartered in Tucson, AZ. | Health Technology |
Cancer Prevention Pharmaceuticals, Inc.
 Cancer Prevention Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cancer Prevention Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of therapeutic agents for the treatment and prevention of certain pre-cancerous conditions, orphan diseases and gastrointestinal conditions. The company’s pipeline consists of Gastrointestinal and Orphan. Cancer Prevention Pharmaceuticals was founded by Dr. Frank Meyskens and Gene Gerner in June 9, 2008 and is headquartered in Tucson, AZ. | Health Technology |
Gyrus Group Ltd.
Gyrus Group Ltd. Medical SpecialtiesHealth Technology Gyrus Group Ltd. designs, develops, manufactures and markets electro-surgical systems. It operates in four segments: surgical, urology, gynaecology, ent, and partnered technologies. The firm supplies medical devices which reduce trauma and complications in surgery and develops tissue management systems, instruments and services. Gyrus Group was founded in 1989 and is headquartered in London, the United Kingdom. | Health Technology |
Becton Dickinson Immunocytometry Systems
Becton Dickinson Immunocytometry Systems Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Becton Dickinson Immunocytometry Systems manufactures medical instruments. The company is based in San Jose, CA. | Health Technology |
Arizona Cancer Center
Arizona Cancer Center Miscellaneous Commercial ServicesCommercial Services Part of University of Arizona, Arizona Cancer Center provides clinical and medical research services. The company is based in Tucson, AZ. | Commercial Services |
